Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report

Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients

(2021) Emma Guttman‐Yassky et al.   ALLERGY

Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata

(2021) Alessio Gambardella et al.   Dermatitis

Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication

(2021) Morgan Murphrey et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Loss-of-function variants in C3ORF52 result in localized autosomal recessive hypotrichosis

(2020) Liron Malki et al.   GENETICS IN MEDICINE

JAK inhibitors for alopecia areata: a systematic review and meta-analysis

(2019) Kevin Phan et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Dupilumab and alopecia: A Janus effect

(2019) Cataldo Patruno et al.   Dermatologic Therapy

Follow-Up Study of the First Genome-Wide Association Scan in Alopecia Areata: IL13 and KIAA0350 as Susceptibility Loci Supported with Genome-Wide Significance

(2012) Dagny Jagielska et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY